Latest Articles

Publication Date
Does Chemoradiotherapy Boost Survival in Endometrial Cancer? - Medscape

Does Chemoradiotherapy Boost Survival in Endometrial Cancer? Medscape

Published: Jan. 21, 2025, 9:45 a.m.
EC approves GSK’s Jemperli-chemo combo for endometrial cancer - Pharmaceutical Technology

EC approves GSK’s Jemperli-chemo combo for endometrial cancer Pharmaceutical Technology

Published: Jan. 21, 2025, 9:35 a.m.
GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer - Medical Dialogues

GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer Medical Dialogues

Published: Jan. 21, 2025, 8 a.m.
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer - Indian Pharma Post

European Commission expands Jemperli plus chemotherapy approval for endometrial cancer Indian Pharma Post

Published: Jan. 21, 2025, 4:36 a.m.
17 cancer symptoms you should never ignore as record number of people living with disease - Surrey Live

17 cancer symptoms you should never ignore as record number of people living with disease Surrey Live

Published: Jan. 21, 2025, 12:01 a.m.
Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer - OncLive

Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer OncLive

Published: Jan. 20, 2025, 9:34 p.m.
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer - Cancer Network

Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer Cancer Network

Published: Jan. 20, 2025, 5:08 p.m.
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use - PMLiVE

GSK’s Jemperli combination approved by EC for expanded endometrial cancer use PMLiVE

Published: Jan. 20, 2025, 12:33 p.m.
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment - DirectorsTalk Interviews

GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment DirectorsTalk Interviews

Published: Jan. 20, 2025, 7:28 a.m.
GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment - TipRanks

GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment TipRanks

Published: Jan. 20, 2025, 7:19 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!